Mistral Pharma Submits a Provisional Patent Application for a New Oral Delivery Platform (SYS-CON Media)

Mistral Pharma Submits a Provisional Patent Application for a New Oral Delivery Platform (SYS-CON Media)
Mistral Pharma Inc. (TSX Venture:MIP) announced today that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) for a new oral drug delivery platform to be used in some of its pipeline development projects. This oral drug delivery platform was developed by Mistral’s Vice President of R&D, Dr. Alain Desjardins and senior formulator Najiba …